Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

November 13, 2014
Bioniche Life Sciences Inc. Announces Results of Annual General Meeting of Shareholders SHAREHOLDERS

November 12, 2014
Bioniche Life Sciences Inc. Reports MCNA Update & First Quarter Results


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Investor FAQ

Where are your shares traded?

Bioniche shares trade on the Toronto Stock Exchange under the symbol "BNC".

When did Bioniche go public?

Bioniche Inc. became a public company on February 1, 1992. In July, 1999, Bioniche Inc. was amalgamated with Vetrepharm and Renaissance Life Sciences, a holding company, to form Bioniche Life Sciences Inc., operating both animal and human health businesses under one corporate umbrella.

When is the your fiscal year-end?

The Bioniche fiscal year ends June 30th.

Who are your auditors?

The company's auditors are Ernst & Young, LLP of Montréal, Québec.

Who is your legal counsel?

The Company's legal counsel is Norton Rose Fulbright, Toronto, Ontario.

Who is your transfer agent?

CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
P.O. Box 700, Station B
Montreal, QC, H3B 3K3
Tel: 1 (800) 387-0825 / (416) 682-3860
Fax: 1 (888) 249-6189

Who are the members of the Bioniche Board of Directors?

Biographies of the Bioniche senior management team and a listing of the company's Board members can be found here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy